Stay updated on BIO89-100 Multiple Dose in NASH Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.

Latest updates to the BIO89-100 Multiple Dose in NASH Clinical Trial page
- Check7 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, shown with a basic HTML structure and site footer, indicating restricted access to the study information.SummaryDifference20%

- Check42 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a software version upgrade. It represents a backend update reflected in the page's revision label.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 to reflect an updated page version; no content changes or UI changes are introduced.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page version. This does not change the visible content or functionality on the study page.SummaryDifference0.0%

Stay in the know with updates to BIO89-100 Multiple Dose in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.